Institutional Ownership Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the 1,492 institutions that hold shares in the stock, with a total of 85.8 Million shares, which have been reported (via 13F filing form) to have a value of $59.2 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ropes Wealth Advisors LLC
Boston, MA |
Oct 19, 2023 Q3 2023 |
396
shares
|
$273,042
0.06% of portfolio
|
Q3 2023
Reduced 4.12%
|
|
|
Skopos Labs, Inc.
Riverhead, NY |
Jan 15, 2025 Q4 2024 |
394
shares
|
$271,663
0.08% of portfolio
|
Q4 2024
Reduced 24.23%
|
|
|
Enclave Advisors LLC
Austin, TX |
Jan 16, 2025 Q4 2024 |
392
shares
|
$270,284
0.05% of portfolio
|
Q4 2024
Added 31.54%
|
|
|
Aspiriant, LLC
|
Jan 16, 2025 Q4 2024 |
387
shares
|
$266,836
0.01% of portfolio
|
Q4 2024
Added 14.5%
|
|
|
Csenge Advisory Group
|
Jan 30, 2025 Q4 2024 |
387
shares
|
$266,836
0.02% of portfolio
|
Q4 2024
Reduced 16.41%
|
|
|
Ascent Group, LLC
|
Feb 21, 2025 Q4 2024 |
387
shares
|
$266,836
0.02% of portfolio
|
Q4 2024
Reduced 17.66%
|
|
|
Berger Financial Group, Inc
Plymouth, MN |
Feb 14, 2025 Q4 2024 |
385
shares
|
$265,457
0.02% of portfolio
|
Q4 2024
Reduced 1.53%
|
|
|
Strategic Investment Advisors
Farmington Hills, MI |
Jan 22, 2025 Q4 2024 |
385
shares
|
$265,457
0.03% of portfolio
|
Q4 2024
Added 8.76%
|
|
|
Physicians Financial Services, Inc.
Raleigh, NC |
Feb 03, 2025 Q4 2024 |
385
shares
|
$265,457
0.08% of portfolio
|
Q3 2024
Reduced 2.53%
|
|
|
Gradient Capital Advisors, LLC
|
Jan 29, 2025 Q4 2024 |
384
shares
|
$264,768
0.09% of portfolio
|
Q3 2022
New holding
|
|
|
Platte River Wealth Advisors, LLC
|
Oct 07, 2024 Q3 2024 |
383
shares
|
$264,078
0.11% of portfolio
|
Q4 2023
Reduced 1.29%
|
|
|
Axq Capital, LP
Jersey City, NJ |
Feb 11, 2025 Q4 2024 |
382
shares
|
$263,389
0.12% of portfolio
|
Q4 2024
Reduced 69.56%
|
|
|
Tiedemann Advisors, LLC
|
Nov 14, 2023 Q3 2023 |
380
shares
|
$262,010
0.01% of portfolio
|
Q2 2023
Reduced 1.04%
|
|
|
Rock Point Advisors, LLC
Burlington, VT |
Feb 13, 2025 Q4 2024 |
380
shares
|
$262,010
0.08% of portfolio
|
Q4 2023
Reduced 5.0%
|
|
|
Marino, Stram & Associates LLC
|
Jan 17, 2025 Q4 2024 |
376
shares
|
$259,252
0.06% of portfolio
|
Q4 2024
Added 1.08%
|
|
|
Dunhill Financial, LLC
London, X0 |
Feb 14, 2025 Q4 2024 |
375
shares
|
$258,562
0.12% of portfolio
|
Q4 2024
Added 179.85%
|
|
|
Avitas Wealth Management LLC
|
Jan 27, 2025 Q4 2024 |
372
shares
|
$256,494
0.04% of portfolio
|
Q4 2024
Added 12.73%
|
|
|
Mmbg Investment Advisors Co.
|
Feb 14, 2025 Q4 2024 |
370
shares
|
$255,115
0.03% of portfolio
|
Q4 2024
New holding
|
|
|
Welch Group, LLC
|
Jan 24, 2025 Q4 2024 |
368
shares
|
$253,736
0.01% of portfolio
|
Q4 2024
Added 2.22%
|
|
|
Ifp Advisors, Inc
|
Feb 04, 2025 Q4 2024 |
368
shares
|
$253,736
0.01% of portfolio
|
Q4 2024
Added 17.2%
|
|
|
Forefront Analytics, LLC
West Conshohocken, PA |
Feb 13, 2025 Q4 2024 |
368
shares
|
$253,736
0.12% of portfolio
|
Q4 2024
Added 23.91%
|
|
|
Phraction Management LLC
Stamford, CT |
Jan 29, 2025 Q4 2024 |
367
shares
|
$253,046
0.1% of portfolio
|
Q2 2023
Reduced 20.56%
|
|
|
Cary Street Partners Investment Advisory LLC
Richmond, VA |
Feb 14, 2025 Q4 2024 |
366
shares
|
$252,357
0.17% of portfolio
|
Q4 2024
Reduced 91.02%
|
|
|
Douglass Winthrop Advisors, LLC
New York, NY |
Feb 11, 2025 Q4 2024 |
364
shares
|
$250,978
0.01% of portfolio
|
Q4 2024
Added 70.09%
|
|
|
Cipher Capital LP
New York, NY |
May 15, 2024 Q1 2024 |
363
shares
|
$250,288
0.17% of portfolio
|
Q1 2024
Reduced 29.38%
|